The authors experimentally validated the data by western blotting and found that the levels of TRIB1 protein were elevated in 6 out of 8 (75%) CRC tumors when compared to matched adjacent non-tumor tissue. This evidence concerns the gene TRIB1 and colorectal carcinoma.